Ruan et al. established that the usage of a traditional Chinese prescription called Dayuanyin (DYY) for COVID-19, which acted on key targets consisting ofIL-6, IL-1β1B, and CCL2 via IL-17 and the AGE-RAGE signaling pathways in diabetic complications, as well as cytokine-cytokine receptor interplay. This evidence concerns the gene CCL2 and COVID-19.